Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Operating Expenses (2020 - 2025)

Historic Operating Expenses for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $356.4 million.

  • LifeStance Health's Operating Expenses rose 1398.38% to $356.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 703.45%. This contributed to the annual value of $1.3 billion for FY2024, which is 303.53% up from last year.
  • LifeStance Health's Operating Expenses amounted to $356.4 million in Q3 2025, which was up 1398.38% from $348.3 million recorded in Q2 2025.
  • LifeStance Health's 5-year Operating Expenses high stood at $356.4 million for Q3 2025, and its period low was $144.0 million during Q1 2021.
  • For the 5-year period, LifeStance Health's Operating Expenses averaged around $294.1 million, with its median value being $308.0 million (2023).
  • In the last 5 years, LifeStance Health's Operating Expenses skyrocketed by 35776.97% in 2021 and then plummeted by 1410.51% in 2022.
  • Over the past 5 years, LifeStance Health's Operating Expenses (Quarter) stood at $303.8 million in 2021, then decreased by 9.34% to $275.4 million in 2022, then rose by 13.62% to $312.9 million in 2023, then grew by 3.69% to $324.4 million in 2024, then grew by 9.86% to $356.4 million in 2025.
  • Its Operating Expenses stands at $356.4 million for Q3 2025, versus $348.3 million for Q2 2025 and $331.4 million for Q1 2025.